Menu
Back to Journals » Drug Design, Development and Therapy » Volume 13
Research Letter
A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,933 | Dovepress* | 8,001+ | 1,232 | 9,233 | |
| PubMed Central* | 932 | 156 | 1,088 | ||
| Totals | 8,933 | 1,388 | 10,321 | ||
| *Since 24 January 2019 | |||||
View citations on PubMed Central and Google Scholar